Compared with SB, both modalities resulted in a significant increase in VT (by 40% and 36% with PAV and PSV, respectively, on average) and V E (by 37% and 35%) with unchanged breathing frequency and duty cycle. Both modalities significantly reduced esophageal (by 39% and 51%) and diaphragmatic (by 42% and 63%) pressure-time products, respectively. Ineffective efforts were observed with neither modes of assistance in any patient. Conclusions: In resting, awake patients in clinically stable condition with CVF caused by either COPD or RCWD, noninvasive application of PAV, set at the patient's comfort, was not superior to PSV either in increasing VT and V E or in unloading the inspiratory muscles. We failed to find any difference in patient/ventilator interaction between ventilatory modes.
L ong-term noninvasive positive pressure ventilation (NPPV) is used widely in the management of chronic ventilatory failure (CVF) that results from restrictive chest wall disease (RCWD) and from COPD 1 ; however, particularly in the latter, a strong evidence of significant clinical benefit is lacking. 2, 3 Pressure support ventilation (PSV) is the most common mode of providing ventilatory assistance in the long-term setting, with and without some level of positive end-expiratory pressure (PEEP). 4, 5 Studies have shown that proportional assist ventilation (PAV) 6 provides some physiologic benefit in patients with CVF by improving the breathing pattern and arterial blood gases, 7 decreasing breathlessness during exercise, 8, 9 and unloading the respiratory muscles. 10 The theoretic background suggests that these effects of PAV should be associated with a better patient/ventilator interaction because PAV shifts the control of ventilatory assistance from the caregiver to the patient. In fact, the pattern of mechanical breath is proportional to the amplitude and timing of the patient's ventilatory demand. 6 However, this theoretic advantage was never tested in the clinical practice of NPPV. Among others, one reason might be that a direct comparison between PAV and PSV was never performed to understand whether the former may improve the patient's acceptability of long-term NPPV. This study was undertaken to investigate whether PAV will provide a better patient/ventilator interaction than PSV, and thus a better acceptability in patients requiring long-term use of noninvasive ventilation.
Materials and Methods
The investigative protocol was approved by the Ethics Committee of the S. Maugeri Foundation IRCCS. The study was conducted according to the declaration of Helsinki. Patients gave their informed consent to participate in the study.
Patients
The study was conducted in the Lung Function Units of Gussago and Veruno, S. Maugeri Foundation, from March 1999 to March 2000. Eighteen patients (11 patients with COPD and 7 patients with RCWD caused by kyphoscoliosis) with CVF were recruited for this study. Diagnosis of COPD was made according to the American Thoracic Society. 11 The diagnosis of CVF was based on the clinical records showing values of Paco 2 persistently Ͼ 45 mm Hg during room air spontaneous breathing (SB) in the months if not years preceding the study. All patients were in stable clinical condition, as assessed by an arterial pH Ͼ 7.35 and were free from exacerbations in the preceding 4 weeks. Patients with other chronic organ failure, cancer, or inability to cooperate were also excluded from the study. All of the patients were receiving drug treatment according to the prescriptions of their primary physicians. In particular, patients with COPD were receiving regular treatment with inhaled bronchodilators, avoiding either systemic or inhaled steroids apart from exacerbations. At the time of the study, 16 of the 18 patients were receiving long-term oxygen therapy. Six patients with COPD and two patients with RCWD had been receiving long-term home NPPV by nasal mask for 16 to 36 months, with volume-cycled ventilators in assisted mode for two patients, and with pressure-cycled ventilators in PSV mode for six patients. Indications for long-term NPPV for these patients were chronic hypercapnia and nocturnal hypoventilation for all patients. The mean use of NPPV was approximately 7 h per night. Six of 18 patients were admitted to the hospital for indication of domiciliary NPPV. Four of these six patients were discharged with home NPPV. The other patients underwent respiratory rehabilitation programs. The patients' characteristics, according to their diagnoses, are shown in Table 1 .
Measurements
Lung function and arterial blood gas levels were assessed 1 to 3 days before the study. Routine static and dynamic lung volumes were measured with constant volume body plethysmographs (CAD-NET system 1085; Medical Graphics; St. Paul, MN, and V max Series/6200 Autobox DL; SensorMedics; Yorba Linda, CA) with the patients in the seated position according to standard procedure. 12 The predicted values of Quanjer 13 were used. Arterial blood was sampled at the radial artery with the patients in a semirecumbent position and breathing room air. Pao 2 , Paco 2 , and pH were measured with automated analyzers (model 840; Ciba Corning; Medfield, MA, and ABL 620; Radiometer; Copenhagen, Denmark).
For the experimental procedure of this study, flow was measured using a heated pneumotachograph (Fleisch n°1; Fleisch; Lausanne, Switzerland) connected to a flow transducer (HewlettPackard 47304A; Hewlett-Packard; Cuppertino, CA) inserted between the nasal mask and the plateau valve of the ventilator 
Data Analysis
All signals were digitized by an analog-to-digital converter with 12-bit resolution, connected to a personal computer, at a sampling frequency of 100 Hz. Subsequent analyses of breathing pattern and pulmonary mechanics were performed using an edition of the software package (ANADAT 5.2; RHT-Infodat; Montreal, PQ, Canada) interfaced with the respiratory monitoring system used in the present study.
Using the Abreath facility of ANADAT, the mean value of each physiologic variable was computed and used subsequently for statistical analysis. Tidal volume (Vt), respiratory frequency, minute ventilation (V e), total cycle duration, inspiratory time, expiratory time, and duty cycle (Ti/Ttot) were calculated from the flow signal as average values from 5 min of continuous recording of flow and volume. Breathing pattern variability was also computed on flow tracing and expressed as coefficient of variation (SD/mean ϫ 100). Dynamic intrinsic PEEP (PEEPi,dyn) was measured as the negative deflection in Pes from the onset of the inspiratory effort to the start of the inspiratory flow. In the presence of expiratory muscle activity, the value of PEEPi,dyn was reduced by the decrease in Pga measured in the same time interval. 15 Changes in the magnitude of the inspiratory muscles and diaphragm effort were estimated from changes in Pes and Pdi swings, respectively, as well as from changes in the pressure-time product of the inspiratory muscles calculated over a period of 1 min (PTPes) and pressure-time product of the diaphragm calculated over a period of 1 min (PTPdi). 15 The latter measurements were expressed also as pressure developed per liter of ventilation (PTPes/V e and PTPdi/V e). Transpulmonary pressure was used to calculate dynamic elastance (El,dyn) according to the Mead and Whittenberger technique, 16 and pulmonary resistance at midinspiration (Rl) according to the Neergaard-Wirtz elastic subtraction technique. 16 The maximal positive level of Pao signal (peak Pao) was calculated as average values from 10 consecutive respiratory acts in which breathing pattern and mechanics were calculated. In addition, the average area subtended by Pao of the same tidal swings, from the onset of inspiratory effort to the inspiratory flow tracing inversion (from inspiration to expiration) was computed and calculated over a period of 1 min, multiplying it for respiratory rate (mean Pao computed over a period of 1 min
Patients' inspiratory efforts that were unable to trigger a new ventilator cycle despite a negative deflection in Pes were termed ineffective efforts (IE). 17 The mean number of IE per minute, recorded over 5 min, was expressed as percentage of the respiratory rate (IE per minute/respiratory frequency [beats per minute] ϫ 100). 
Ventilatory Settings
A commercial nasal mask of adequate size for each patient's nose was used (Respironics; Murrysville, PA). In each patient, both modalities were delivered using the same portable ventilator able to compensate for leaks and to operate in the continuous positive airway pressure (CPAP) mode, PSV mode, and PAV mode (BiPAP Vision; Respironics). The ventilator circuit was equipped with the Sanders NRV-2 plateau valve (Respironics) to prevent CO 2 rebreathing. 14 Before starting the protocol, PAV and PSV settings were separately assessed as follows.
PAV: The ventilator delivers pressure according to the motion equation, generating a pressure that is proportional to patient's spontaneous effort. 6 A portion of the total mechanical workload, ie, elastance and resistance, is taken over according to a level of assistance, which has been decided by the caregiver and can specifically unload the resistive burden (flow assist [FA] ) and the elastic burden (volume assist [VA] ). VA and FA were set separately; VA and FA were set initially at the minimum value of 2 cm H 2 O/L/s and 1 cm H 2 O/L/s, respectively, in all patients. Then, leaving FA unchanged, VA was increased slowly by steps of 2 cm H 2 O/L until the patient indicated that breathing was uncomfortable. Each step lasted the time necessary for the ventilatory setting to be described as comfortable or uncomfortable. Then, that level of assist was decreased by 2 cm H 2 O/L. This level was considered as the maximum tolerated. To set FA, a similar stepwise approach was used, by keeping VA at 2 cm H 2 O/L and slowly increasing FA from 1 cm H 2 O/L/s by small steps of 1 cm H 2 O/L/s until the patient noted being uncomfortable with that level of assistance. Then, that level of assistance was decreased by 1 cm H 2 O/L/s. This level was considered to be the maximum tolerated. The setting of PAV that was applied to patients corresponded to 80% of the maximal individual tolerated values of VA and FA. 10 Those values of FA and VA were used to evaluate the residual pulmonary resistance (⌬Rl) and residual lung elastance (⌬El,dyn) faced by respiratory muscle contraction to generate inspiratory flow and volume, being subtracted from Rl (⌬Rl ϭ Rl Ϫ FA) and El,dyn (⌬El,dyn ϭ El,dyn Ϫ VA), respectively. No data were available about the residual resistance and elastance of the chest wall.
PSV: The level of inspiratory pressure support (IPS) was increased slowly by steps of 2 cm H 2 O, starting from 2 cm H 2 O, until the patients indicated that breathing was uncomfortable. Hence, that level of IPS was decreased by 2 cm H 2 O, and the resultant level was applied. A default level of 2 cm H 2 O of CPAP was added to both modalities in each individual patient.
Experimental Procedure
The whole procedure was performed under continuous monitoring of arterial oxygen saturation by pulse oximetry (Oxicap Monitor; Ohmeda; Louisville, CO). The patients were evaluated in the morning (patients with COPD were evaluated at least 2 h after inhalation of their bronchodilating medications) and were free to choose the most comfortable position. All patients adopted a semirecumbent position.
The procedure to evaluate respiratory muscles and mechanics has been extensively detailed elsewhere. 4, 5, 10, 15 Briefly, in all patients, after the application of topical anesthesia (xylocaine spray 10%), two balloon-tipped catheters were consecutively inserted through the nose into the middle third of the esophagus and into the stomach and thereafter inflated to 0.5 mL and 1 mL for the esophageal and gastric catheters, respectively. Then, the nasal mask was applied and connected to the pneumotachograph. The occlusion test 18 was finally performed to check the proper functioning of the esophageal balloon. A pneumatic shutter was inserted in line and proximally to the pneumotachograph only to perform this maneuver, and then removed. The occlusion test was satisfactory in every instance.
Initially, all patients were not connected to the ventilator and breathed room air through the nose mask for approximately 20 min. All of the patients were instructed to breathe through the nose mask and to keep their mouths closed during the experimental procedure to prevent leaks. Subsequently, PAV and PSV were applied in random order for 30 min, and the trials were separated by 20-min periods of SB through the mask. All of the measurements were obtained at an inspiratory oxygen fraction of 0.21.
All of the physiologic signals were recorded in the last 5 min of each unsupported and supported breathing period. In two patients with RCWD, the signal from the gastric balloon was unsatisfactory. Hence, complete data of respiratory muscles and mechanics were available in 16 of 18 patients.
At the end of each period of assistance, 10 patients (5 patients with each diagnosis) of the 18 patients scored their comfort sensation under NPPV by means of an arbitrary scale ranging from 0 (worst comfort) to 10 (best comfort). At the end of the two ventilation sessions, the patients indicated their preferred mode of ventilation. The time spent by the operator to set the two modalities was recorded by an attending nurse.
Statistical Analysis
Results are shown as mean Ϯ 1 SD. Differences between treatments and within treatment were evaluated by analysis of variance for repeated measures. Because of the lack of differences between values assessed during the two SB periods, baseline values were considered as the mean levels of the two measurements. Differences between paired groups of data were evaluated with post hoc paired t test with Bonferroni adjustment and were applied as requested by analysis of variance interaction. A p value Ͻ 0.05 was considered significant.
Results
All patients accepted NPPV well throughout the procedure. No patients reported side effects or refused the procedure with either modality. Because no significant difference between PAV and PSV was found according to the diagnosis, when not specified, data from patients with different diagnoses are reported together.
Setting of the Ventilator
The individual and mean levels of assistance with the two modalities and patients' elastance and resistance are shown in Table 2 . With PAV, no "runaway" phenomenon 6 was observed in any patient. The run-away phenomenon was defined by the continuation of positive pressure after the end of the patients' inspiratory effort into the patients' neural expiration. In this condition, the pressure delivered by the ventilator exceeds the patients' elastic recoil opposing force, generating inspiratory flow and volume well beyond the termination of the inspiratory muscle effort, until total respiratory elastance increases above VA value at total lung capacity. 6 Table 2 also shows patients discharged with home mechanical ventilation. There was no significant difference in levels of VA and FA between patients who required home ventilatory assistance and patients who did not.
Patients with RCWD tolerated higher levels of VA under PAV than patients with COPD. Peak Pao was not significantly different between ventilator modes (11 Ϯ 4 cm H 2 O and 12 Ϯ 3 cm H 2 O with PAV and PSV, respectively). By contrast, PTPao was lower with PAV (151 Ϯ 45 cm H 2 O/s/min) than PSV (207 Ϯ 73 cm H 2 O/s/min; p Ͻ 0.002). During PAV, ⌬Rl and ⌬El,dyn workloads showed a different behavior in patients with COPD and patients with RCWD (Table 2 ). In fact, in patients with RCWD, VA was above the El,dyn, whereas ⌬Rl fell within normal limits. 19 By contrast, in patients with COPD, ⌬El,dyn fell within normal limits, and, on average, ⌬Rl was mildly increased ( Table 2 ). The caregivers spent more time to set PAV than PSV (663 Ϯ 179 s and 246 Ϯ 58 s, respectively; p Ͻ 0.001). Figure 2 shows a polygraphic tracing from a representative patient during the different conditions of the study protocol. Ineffective efforts were not observed with either modes of assistance in any patient. In the breathing pattern, Vt showed a greater variability under PAV than under PSV (coefficient of variation, 16.3% Ϯ 10.5% and 11.6% Ϯ 7.7%, respectively; p Ͻ 0.01).
Breathing Pattern and Lung Mechanics
Mean values of breathing pattern and lung mechanics during SB and assisted ventilation are shown in Table 3 . On average, both PAV and PSV improved Vt (by 40% and 36%, respectively), V e (by 37% and 35%, respectively), and mean inspiratory flow (by 33% and 51%, respectively) without changes in respiratory frequency and Ti/Ttot. Neither mode modified El,dyn or Rl compared with baseline. Table 4 shows that on average, the magnitude of the patients' inspiratory muscle effort was significantly reduced by both PAV and PSV, which resulted in lower Pes (Ϫ 33% and Ϫ 51%), Pdi (Ϫ 34% and Ϫ 52%), PTPes (Ϫ 39% and Ϫ 51%), PTPdi (Ϫ 42% and Ϫ 63%), PTPes/V e (Ϫ 53% and Ϫ 63%), and PTPdi/ V e (Ϫ 56% and Ϫ 72%, respectively; Fig 3) . Although there was no significant difference, PSV unloaded the inspiratory muscles slightly more than PAV.
Inspiratory Muscles

Comfort
Comfort score was available in 10 patients (5 patients with COPD and 5 patients with RCWD). No patients rated low scores of comfort under either modality of ventilation, indicating good adaptation to NPPV (7.0 Ϯ 1.3 and 7.4 Ϯ 1.6 for PAV and PSV, respectively). Moreover, no significant difference was found between scores during PAV and PSV. There was no clear preference about a specific ventilatory mode because six patients preferred PSV and four patients preferred PAV.
Discussion
The results of this study show that in resting, awake patients in clinically stable condition with CVF caused by either COPD or RCWD, noninvasive application of PAV, set at the patient's comfort, was not superior to PSV either in increasing Vt and V e and or in unloading the inspiratory muscles. The only differences between PSV and PAV were that the latter achieved those physiologic benefits at a lower level of PTPao but required more time to set the ventilator. We failed to find any difference in patient/ventilator interaction between ventilatory modes.
This study confirms and extends previous observations, 4, 5, 10 but it provides the first comparison in the NPPV setting between PAV, a recently proposed mode of mechanical ventilation, and PSV, which still remains the most widely used mode of ventilatory assistance for both short-term and long-term patients. 1 In patients with COPD and in patients with RCWD, the magnitude of improvement in V e and Vt (Table 3) , as well as the amount of the reduction of the patients' inspiratory effort (Table 4) , were not significantly different between PAV and PSV, although PSV determined a slightly greater reduction of patients' effort, on average. Similar changes in breathing pattern 7 and respiratory mechanics 10 were obtained in our previous studies with PAV. In this connection, it should be mentioned that all of the patients in this study and in the previous studies 7, 10 were receiving low levels of CPAP, which contributed to the reduction of the patients' inspiratory effort. 4, 15 A direct comparison between PAV and PSV was performed in intubated patients with acute respiratory failure. 20 -22 The settings (ie, ICUs), the patients (ie, in acute condition), and the method of delivering mechanical ventilation (ie, through the endotracheal tubes) are too different from the conditions of our study to make any comparison. However, it should be mentioned that in those studies, 20 -22 PAV allowed a greater variability of Vt than PSV in the face of an increased ventilatory demand. Also in our study, patients receiving PAV showed a greater variability of Vt than those receiving PSV. However, we failed to find any significant clinical benefit from this difference in our long-term patients. In fact, none of the two modes (ie, PAV or PSV) prevailed in the patients' choice of a greater comfort. This might be caused by the fact that, among others, both modalities were set at the patients' comfort since the beginning of the procedure, whereas in the acute settings, PAV was set after measuring the patients' respiratory mechanics using the occlusion technique. 20 -22 This procedure, which might allow a better physiologic tailoring of the level of assistance following the theoretic background of PAV, can be applied without discomfort in ventilator-dependent patients, but it is difficult to use in awake patients reacting to the airway occlusion. Furthermore, NPPV needs patients' cooperation, which cannot be obtained in condition of discomfort. Therefore, regardless the mode of mechanical assistance, the ventilator must be set at the patient's comfort to ensure cooperation.
In comparing different modalities of mechanical ventilation, a major problem is to avoid the risk to match up to "apples and oranges." 23 In our study, this risk was reduced by a few issues. First, the same ventilator was used to deliver the mechanical assistance. Second, the two modes were applied according to a random order with a similar period (30) of spontaneous, unsupported breathing before each mode. Third, the patients were in stable clinical condition; therefore, it is unlikely that changes in the patient's state might affect the results of the physiologic measurements. Finally, both PSV and PAV were set with the same procedure, namely at the patient's comfort.
Having obtained similar physiologic results, PAV was associated with a lower mean Pao, as assessed by PTPao, than PSV (151 Ϯ 45 cm H 2 O/s/min vs 207 Ϯ 73 cm H 2 O/s/min). This may be relevant in view of studies 24 showing that NPPV can significantly reduce cardiac output in patients with COPD. It could be extrapolated that the lower mean Pao with PAV was likely to determine less changes in the patients' hemodynamics than PSV. However the lower mean Pao with PAV was associated with a trend to less respiratory muscle unloading than with PSV.
PAV required a longer time to be set. There are two possible explanations for this finding. First, PAV is not common in the clinical practice, whereas PSV is the most widely used mode of NPPV. Conceivably, the caregivers are far more familiar with PSV than with PAV. In these circumstances, the time to set PAV will be remarkably reduced by practice. Second, with PSV only Pao must be regulated whereas with PAV two independent variables (ie, VA and FA) must be coordinated. Although the manufacturers are trying to simplify this issue, there is little doubt that at present the setting of PAV requires more time and awareness than PSV. Time might not be so relevant for long-term patients in stable condition, but it may be crucial for patients needing mechanical ventilation to treat acute respiratory failure.
In line with previous studies, 25 both PAV and PSV unloaded the patients' respiratory muscles without causing changes in lung mechanics (Tables 3, 4 ). The low levels of PEEPi,dyn in our patients with COPD are not surprising in view of their stable conditions.
The most interesting aspect of Table 2 is the comparison between the levels of assistance (VA and FA) and patients' lung mechanics (lung resistance and elastance). Apparently, FA underassisted the resistive component in patients with COPD, whereas VA overassisted the elastic component in patients with RCWD. The first of these results is in line with our previous study. 10 Similar to those patients, most of the patients with COPD in this study also did not tolerate levels of FA Ͼ 5 cm H 2 O/L/s. The present study was not tailored to address directly this finding, but it can be hypothesized that patients with COPD, by means of dyspnea perception, chose a low level of FA to avoid excessive increase in Vt, thus protecting themselves from the development of dangerous levels of dynamic hyperinflation and intrinsic PEEP. In fact, dynamic hyperinflation is known to increase dyspnea perception in patients with COPD. 26 Moreover, the fact that FA algorithm is linear, and Rl during inspiration is not, 6 may add to the above hypothesis. It may be that early during inspiration, Rl was underassisted because of its high value; on the contrary, with increasing the inspiratory volume and airway caliber, FA might have been better matched to a decreasing Rl. In a recent study, Younes and colleagues 27 suggested a new method for measuring resistance to set PAV in intubated patients with acute respiratory failure. Whether that method may allow a better tailoring of FA also with NPPV remains to be established in the clinical setting.
Finally, the present study does not provide experimental data explaining the apparent VA overassistance of the patients with RCWD. In fact we could only measure El,dyn, whereas in patients with RCWD the major mechanical abnormality is well known to be related to stiff chest wall. Chest wall elastance could not be measured in this study, but it can be assumed to be greater than the level of VA overassistance indicated by ⌬El,dyn. This hypothesis is indirectly supported by the fact that the run-away phenomenon was not observed when VA overwhelmed lung elastance. All together, the above data on chest wall and lung mechanics suggest that the measurement of lung mechanics using the esophageal catheter system can be not only uncomfortable for the patients, but also of little help to set PAV for clinical purposes when chest wall mechanics abnormalities are present. The regulation at patient's comfort still seems the most acceptable way to set any mode of NPPV in the common clinical situation. 5 
Limitations of the Study
PAV has been designed to assist the respiratory muscles in coping with changes of the ventilatory demand. 6 This particular feature of PAV should distinguish it from other modes of ventilatory assistance. This study failed to show any advantage of PAV over PSV to claim as relevant for clinical purposes, apart from the lower mean Pao. However we documented that PAV behaved as well as PSV under resting conditions in very sick patients in stable clinical condition.
Our study was performed in awake patients, whereas home NPPV is usually prescribed at night. Therefore, the correct ventilator setting theoretically should be tested during a formal sleep study. Nevertheless, we think that the lack of studies of comparison of PAV and PSV would warrant a daytime investigation, in particular when one takes into account the invasive techniques needed to measure patient's respiratory muscle function. Furthermore, daytime mechanical ventilation in awake patients was reported to be as equally effective in reversing chronic hypercapnia as nocturnal mechanical ventilation. 28 In conclusion, in resting, awake patients in clinically stable condition with CVF, noninvasive application of PAV, set at patient's comfort, was not superior to PSV either in increasing Vt and V e, in unloading the inspiratory muscles, or in patient/ ventilator interaction.
